Anzeige
Mehr »
Samstag, 07.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A41BED | ISIN: SE0024173637 | Ticker-Symbol: 7AL0
Frankfurt
06.06.25 | 21:38
0,325 Euro
-0,85 % -0,003
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
ALLIGATOR BIOSCIENCE AB Chart 1 Jahr
5-Tage-Chart
ALLIGATOR BIOSCIENCE AB 5-Tage-Chart

Aktuelle News zur ALLIGATOR BIOSCIENCE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiBiomarker Data from Alligator Bioscience's OPTIMIZE-1 Trial Presented at ASCO 2025 Annual Meeting151LUND, SE / ACCESS Newswire / June 3, 2025 / Alligator Bioscience (Nasdaq Stockholm:ATORX) today announced that biomarker data from its OPTIMIZE-1 clinical trial were presented at the 2025 American Society...
► Artikel lesen
26.05.Alligator Bioscience AB Carries Out Directed Issues to Guarantors in Connection with Exercise of Warrants Series TO 12325LUND, SE / ACCESS Newswire / May 26, 2025 / Alligator Bioscience (STO:ATORX)NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA...
► Artikel lesen
26.05.Alligator Bioscience Announces European Orphan Drug Designation for HLX22 in Gastric Cancer271LUND, SE / ACCESS Newswire / May 26, 2025 / Alligator Bioscience (STO:ATORX) - Lund, Sweden - 26 May 2025 - Alligator Bioscience (Nasdaq Stockholm: ATORX) today announces that the European Commission...
► Artikel lesen
23.05.Alligator Bioscience Presents OPTIMIZE-1 Biomarker Data at ASCO 2025 Annual Meeting266LUND, SE / ACCESS Newswire / May 23, 2025 / Alligator Bioscience (Nasdaq Stockholm:ATORX) today announced the presentation of biomarker data from its OPTIMIZE-1 clinical trial at the 2025 American Society...
► Artikel lesen
21.05.Alligator Bioscience AB Announces Final Outcome of Exercise of Warrants Series TO 12196LUND, SE / ACCESS Newswire / May 21, 2025 / Alligator Bioscience (STO:ATORX)NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA...
► Artikel lesen
20.05.Alligator Bioscience Announces Paediatric Study Waiver for Mitazalimab Granted by the European Medicines Agency228LUND, SE / ACCESS Newswire / May 20, 2025 / Alligator Bioscience (Nasdaq Stockholm:ATORX), a clinical stage biotechnology company pioneering immuno-oncology therapeutics, today announced that the European...
► Artikel lesen
ALLIGATOR BIOSCIENCE Aktie jetzt für 0€ handeln
20.05.Alligator Bioscience AB Announces Preliminary Outcome of Exercise of Warrants Series TO 12220LUND, SE / ACCESS Newswire / May 20, 2025 / Alligator Bioscience (STO:ATORX)NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA...
► Artikel lesen
15.05.Last Day of Trading in Warrants Series TO 12 in Alligator Bioscience is 15 May 2025213LUND, SE / ACCESS Newswire / May 15, 2025 / Alligator Bioscience (STO:ATORX)NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA...
► Artikel lesen
12.05.Alligator Bioscience to Attend ASCO 2025 Annual Meeting243LUND, SE / ACCESS Newswire / May 12, 2025 / Alligator Bioscience (Nasdaq Stockholm:ATORX) is pleased to announce that data from its OPTIMIZE-1 clinical trial will be presented at the 2025 American Society...
► Artikel lesen
09.05.Alligator Bioscience Announces that 85% of the Warrant Programme TO 12 has Been Secured and that the Outstanding Loan has Been Renegotiated303NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA...
► Artikel lesen
09.05.Alligator Bioscience Completes Phase 3 GMP Manufacturing of Mitazalimab, Remains on Track for Trial Initiation with Partner293LUND, SE / ACCESS Newswire / May 9, 2025 / Alligator Bioscience (Nasdaq Stockholm:ATORX) today announced the successful completion of the manufacture of the first GMP drug product batch of its lead...
► Artikel lesen
08.05.Alligator Bioscience Updates Dividend Policy219LUND, SE / ACCESS Newswire / May 8, 2025 / Alligator Bioscience (STO:ATORX) - Alligator Bioscience AB (publ) today announces an update to its dividend policy following the constitution of Alligator's...
► Artikel lesen
07.05.Bulletin from the Annual General Meeting in Alligator Bioscience AB on 7 May 2025238LUND, SE / ACCESS Newswire / May 7, 2025 / Alligator Bioscience (STO:ATORX) - The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation...
► Artikel lesen
30.04.Change in Number of Shares and Votes in Alligator Bioscience AB239LUND, SWEDEN / ACCESS Newswire / April 30, 2025 / During April 2025, the number of shares and votes in Alligator Bioscience AB (STO:ATORX) ("Alligator Bioscience") has decreased as a result of the redemption...
► Artikel lesen
28.04.Exercise Price Determined for the Exercise of Warrants Series TO 12 in Alligator Bioscience AB324NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA...
► Artikel lesen
24.04.Alligator Bioscience AB Reports Financial Results for Q1 2025 and Provides a Business Update319LUND, SE / ACCESS Newswire / April 24, 2025 / Alligator Bioscience (STO:ATORX)24-month data from OPTIMIZE-1 show 29.4% survival rate for mitazalimab-three times higher than chemotherapy aloneFDA alignment...
► Artikel lesen
23.04.Alligator Bioscience Announces Initiation of HLX22 Phase 2 Trial in Breast Cancer by Shanghai Henlius Biotech, Inc.266LUND, SE / ACCESS Newswire / April 23, 2025 / Alligator Bioscience (Nasdaq Stockholm:ATORX) today announces that Shanghai Henlius Biotech, Inc. ("Henlius") has initiated a Phase 2 clinical trial with...
► Artikel lesen
07.04.XFRA NEW INSTRUMENTS AVAILABLE ON XETRA 07.04.2025402The following instruments on XETRA do have their first trading 07.04.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 07.04.2025 Aktien 1 US09260Q1085 BlackRock Technology...
► Artikel lesen
04.04.XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 04.04.2025670The following instruments on Boerse Frankfurt do have their last trading day on 04.04.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 04.04.2025ISIN NameCA00175D1006 AMPD...
► Artikel lesen
04.04.XFRA ISIN CHANGE533Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenAU000000IPL1 Dyno Nobel Ltd. 04.04.2025 AU0000390544 Dyno Nobel Ltd. 07.04.2025 Tausch 1:1SE0000767188 Alligator Bioscience...
► Artikel lesen
Weiter >>
69 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,3